Is a flagship company located at Ahmedabad (India). It produces Bulk drugs and compounds in the therapeutic areas of cardiovascular and central nervous system.

1. Quotient
2. Division Product Math

Torrent Pharma has also entered areas like gastro-intestinal, diabetology, anti-infective and pain management systems. Torrent Pharmaceuticals was set up in the year 1959 and was initially headquartered in Ahmedabad (India). Torrent Pharmaceuticals was derived from the name Trinity Laboratories Ltd. Which was promoted by U. Mehta and now trades in 50 countries with more than 1000 product registration across the globe. Torrent Pharma has drawn a revenue of 13.3 billion for the year 2007 and its net income for the same is 0.9 billion.

TORRENTPH is a flagship company which manufactures Bulk drugs and compounds in the therapeutic areas with main concentration on cardiovascular and central nervous system. Torrent Pharmaceuticals Limited has six divisions for marketing and each division succumbs to the defined therapeutic areas.

Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing.

Quotient

Torrent Pharma has established 22 new conceptualizations in the Indian market and 14 for the international market that includes Europe, Russia and Brazil. TORRENTPH has also launched a subordinate in Brazil and has stretched its focus on Russia and CIS countries during 2004-2005. Five fully owned subordinates of Torrent Pharmaceuticals are. Hardware id trivium keygenguru. Torrent Pharma Inc – USA Torrent Pharmaceuticals Limited also started to export Lamotrigine to the EU market. Torrent Gujarat Biotech, the sister concern of Torrent Pharma, was established in 1992 in order to manufacture Penicillin through fermentation technology developed by the Torrent Group.

TORRENTPH bears the R&D expense of Rs.673.2 million (14.3% of the turn over). With regard to that, Torrent Pharma has launched a R&D center that deals with new chemical entities for vascular complications and metabolic disorders.

Division Product Math

Torrent Pharmaceuticals has also undertaken a project in partnership with AsiaZeneca. The company is also engaged in DPCO (drug price control orders — practiced on 24 drugs at present) which is run under three level of.